406 filings
Page 4 of 21
8-K
eyqys
14 Apr 23
Departure of Directors or Certain Officers
5:01pm
8-K
deoxlow9v6k5d
12 Apr 23
Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors
7:01am
8-K
9drr 759h4iyf2q4lhiu
3 Apr 23
Kineta to Present at 22nd Annual Needham Healthcare Conference
7:01am
8-K
oqpz34s
31 Mar 23
Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
z3f0dmk
31 Mar 23
Regulation FD Disclosure
12:00am
8-K
b8yij 7oid
22 Mar 23
Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023
7:00am
8-K
afd pvknuxa
8 Mar 23
Kineta to Present at the Oppenheimer 33rd Annual Healthcare Conference
7:00am
8-K
vxxg eocfq
6 Mar 23
Regulation FD Disclosure
7:02am
8-K
e9naxup
1 Mar 23
Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board
4:06pm
8-K
it2dzkt
24 Feb 23
Departure of Directors or Certain Officers
4:06pm
EFFECT
rp1i9ah9u mvyhvvv
13 Feb 23
Notice of effectiveness
12:00am
POS AM
vs4io 2ye9
10 Feb 23
Prospectus update (post-effective amendment)
4:54pm
8-K
uznoyenjlrkb6
10 Feb 23
Entry into a Material Definitive Agreement
4:51pm
424B5
twlrcwf
10 Feb 23
Prospectus supplement for primary offering
4:48pm
EFFECT
v9500qmr
31 Jan 23
Notice of effectiveness
12:15am
424B4
i1ciauqp v4
30 Jan 23
Prospectus supplement with pricing info
5:02pm
CORRESP
qfvz35lcxi4d05nm
26 Jan 23
Correspondence with SEC
12:00am
UPLOAD
8its9e
25 Jan 23
Letter from SEC
12:00am